Enterprise Ireland HSE SBIR Challenge Launch
Enterprise Ireland is delighted to announce their Small Business Innovation Research challenge launch with the HSE. The topic of this challenge is Diabetes. Please click here for the full press release. We would really appreciate if you could share this information with any relevant companies, researchers or entrepreneurs that may be interested.
Diabetes is a serious global public health issue which has been described as the most challenging health problem in the 21st century. Between 1998 and 2015, there was a significant increase in the prevalence of doctor diagnosed diabetes among adults in Ireland (increasing from 2.2 % in 1998 to 5.2 % in 2015). The prevalence of undiagnosed diabetes in Ireland ranges from 0.9 – 2.8% of the population. People with diabetes are at serious risk of developing microvascular complications which can result in damage to feet, resulting in loss of sensation, damage to the back of the eye which can lead to blindness and damage to kidneys which can result in kidney failure.
This new SBIR competition specifically targets two key unmet needs:
- Reducing the risk of women developing diabetes following gestational diabetes
- Screening for diabetic foot disease in all patients with diabetes
Development contracts are 100% funded across a two phased process and focused on specific identified needs, increasing the chance of exploitation. Suppliers will be selected by an open competition process and retain the intellectual property generated from the project, with certain rights of use retained by HSE. This is an excellent opportunity to establish an early customer for a new technology and to fund its development. The competition will be run by HSE, supported by EI following the SBIR model.
Please see link to eTenders to apply to the challenge. If you have specific queries on this challenge please post them on the e-tenders link.
Please note we will be holding a briefing event on Tuesday 5th of February 2019 in Galway City. (Details and link for registration to follow)
Click here for more information